Stericycle, Inc. (NASDAQ:SRCL) – Equities research analysts at Jefferies Group dropped their FY2017 earnings estimates for shares of Stericycle in a report issued on Friday. Jefferies Group analyst S. Dodge now expects that the business services provider will post earnings per share of $4.49 for the year, down from their prior estimate of $4.59. Jefferies Group currently has a “Buy” rating and a $108.00 target price on the stock. Jefferies Group also issued estimates for Stericycle’s Q4 2017 earnings at $1.15 EPS and FY2018 earnings at $4.50 EPS.
Stericycle (NASDAQ:SRCL) last announced its quarterly earnings data on Wednesday, November 8th. The business services provider reported $1.10 earnings per share for the quarter, missing the Zacks’ consensus estimate of $1.14 by ($0.04). Stericycle had a negative net margin of 0.79% and a positive return on equity of 13.93%. The business had revenue of $883.00 million during the quarter, compared to analysts’ expectations of $896.81 million. During the same period in the prior year, the firm posted $1.24 EPS. Stericycle’s revenue for the quarter was down .8% compared to the same quarter last year. ILLEGAL ACTIVITY NOTICE: “Jefferies Group Weighs in on Stericycle, Inc.’s FY2017 Earnings (SRCL)” was reported by Markets Daily and is the sole property of of Markets Daily. If you are accessing this story on another website, it was stolen and reposted in violation of U.S. & international copyright legislation. The legal version of this story can be viewed at https://www.themarketsdaily.com/2017/11/13/jefferies-group-weighs-in-on-stericycle-inc-s-fy2017-earnings-srcl.html.
A number of other brokerages have also weighed in on SRCL. Zacks Investment Research lowered Stericycle from a “buy” rating to a “hold” rating in a report on Monday, August 7th. BMO Capital Markets reduced their price target on shares of Stericycle from $74.00 to $62.00 and set a “market perform” rating for the company in a research report on Friday. BidaskClub downgraded shares of Stericycle from a “sell” rating to a “strong sell” rating in a research report on Tuesday, August 1st. Barclays PLC reiterated an “overweight” rating and set a $100.00 price target on shares of Stericycle in a research report on Wednesday, August 9th. Finally, Stifel Nicolaus reiterated a “buy” rating and set a $85.00 price target (down from $95.00) on shares of Stericycle in a research report on Thursday. Four investment analysts have rated the stock with a sell rating, four have issued a hold rating and six have issued a buy rating to the stock. Stericycle has an average rating of “Hold” and a consensus target price of $77.17.
Shares of Stericycle (NASDAQ:SRCL) opened at $64.02 on Monday. Stericycle has a twelve month low of $61.62 and a twelve month high of $88.00. The firm has a market capitalization of $5,465.58, a P/E ratio of 14.75, a price-to-earnings-growth ratio of 1.75 and a beta of 0.19. The company has a debt-to-equity ratio of 0.93, a current ratio of 0.82 and a quick ratio of 0.87.
Several institutional investors have recently modified their holdings of SRCL. Schroder Investment Management Group acquired a new position in shares of Stericycle during the 2nd quarter worth approximately $80,497,000. Thompson Siegel & Walmsley LLC acquired a new position in Stericycle in the 2nd quarter valued at $33,710,000. Strs Ohio raised its holdings in Stericycle by 26,943.3% in the 2nd quarter. Strs Ohio now owns 328,306 shares of the business services provider’s stock valued at $25,056,000 after acquiring an additional 327,092 shares during the last quarter. BlackRock Inc. raised its holdings in Stericycle by 6.4% in the 2nd quarter. BlackRock Inc. now owns 5,413,244 shares of the business services provider’s stock valued at $413,139,000 after acquiring an additional 323,664 shares during the last quarter. Finally, Clarkston Capital Partners LLC raised its holdings in Stericycle by 43.1% in the 3rd quarter. Clarkston Capital Partners LLC now owns 1,013,885 shares of the business services provider’s stock valued at $72,614,000 after acquiring an additional 305,441 shares during the last quarter. Hedge funds and other institutional investors own 94.13% of the company’s stock.
In related news, Director Mark C. Miller sold 19,753 shares of Stericycle stock in a transaction that occurred on Monday, October 30th. The stock was sold at an average price of $70.52, for a total transaction of $1,392,981.56. Following the completion of the transaction, the director now directly owns 205,576 shares in the company, valued at approximately $14,497,219.52. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 3.30% of the company’s stock.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.